Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJMBR (2) Biol. Res. (1) J. Venom. Anim. Toxins incl. Trop. Dis. (1) Autor Ayres-Neto,E.M. (1) Calligaris,Sebastián D (1) Carneiro,J.J. (1) Conget,Paulette (1) Delma,K (1) Drago,A. (1) Grassi,A. (1) Gómez-Alvis,A. (1) Maciel,B.C. (1) Marin-Neto,J.A. (1) Milesi,V. (1) Raingo,J. (1) Rebolledo,A. (1) Rinaldi,G. (1) Sanz,N. (1) Schmidt,A. (1) Tommasi,J. (1) de Almeida-Filho,O.C. (1) Mais... Palavra-chave Dobutamine (4) Acute pulmonary edema (1) Amrinone (1) Animal model (1) Cardiac function (1) Diabetic cardiomyopathy (1) Diltiazem (1) Dipyridamole (1) Echocardiography (1) Mammary artery (1) Metabolic syndrome (1) Multipotent mesenchymal stromal cells (1) Obesity (1) Pacing (1) Saphenous vein (1) Scorpion envenomation (1) Stress echocardiography (1) Mais... Tipo do documento Info:eu-repo/semantics/article (3) Journal article (1) Ano 2013 (1) 2012 (1) 2004 (1) 2001 (1) País Brazil (3) Chile (1) Idioma Inglês (4)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 4 Primeira ... 1 ... Última Echocardiographic changes during acute pulmonary edema subsequent to scorpion sting J. Venom. Anim. Toxins incl. Trop. Dis. Delma,K. Acute pulmonary edema (APE) occurring after scorpion sting is the leading cause of death of the victims of scorpion envenomation. The APE origin is still questioned by physicians treating these patients. Based on echocardiographic study of 20 patients with severe envenomation treated in Ouargla Hospital resuscitation ward during the last four years, the APE etiology seems more likely cardiogenic, referring to cardiac symptoms confirmed by echocardiography although other mechanisms may also be involved. This hypothesis is further confirmed by the positive response of patients to the administration of dobutamine. Tipo: Info:eu-repo/semantics/article Palavras-chave: Scorpion envenomation; Acute pulmonary edema; Echocardiography; Dobutamine. Ano: 2012 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992012000400010 Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells has a neutral effect on obesity-induced diabetic cardiomyopathy Biol. Res. Calligaris,Sebastián D; Conget,Paulette. Obesity is a major global health issue. Obese patients develop metabolic syndrome, which is a cluster of clinical features characterized by insulin resistance and dyslipidemia. Its cardiac manifestation, diabetic cardiomyopathy, leads to heart failure. Bone marrow-derived multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSC) are envisioned as a therapeutic tool not only for cardiovascular diseases but also for other degenerative conditions. Our aim was to evaluate whether the intravenous administration of MSC modifies cardiac dysfunction in obese mice. To this end, C57BL/6 mice were fed a regular (normal) or high-fat diet (obese). Obese animals received the vehicle (obese), a single dose (obese + 1x MSC) or three doses... Tipo: Journal article Palavras-chave: Obesity; Metabolic syndrome; Diabetic cardiomyopathy; Multipotent mesenchymal stromal cells; Cardiac function; Dobutamine. Ano: 2013 URL: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602013000300005 Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization BJMBR Gómez-Alvis,A.; Rebolledo,A.; Milesi,V.; Raingo,J.; Sanz,N.; Tommasi,J.; Drago,A.; Rinaldi,G.; Grassi,A.. Hemodynamic care during postoperative management of myocardial revascularization should include vasorelaxing drugs to insure adequate graft and coronary flow, and stimulation of stroke volume to maintain vascular perfusion pressure. We tested the cardiac (inotropic and lusitropic) and vascular (relaxant) effects of diltiazem (0.1 nM to 0.1 mM), dobutamine (10 µM to 10 mM) and amrinone (10 µM to 1 mM) on isolated rat atria and thoracic aorta, and also on isolated human saphenous vein (HSV) and human mammary artery (HMA). Dobutamine produced a maximal positive inotropic effect (+dF/dt max = 29 ± 7%) at its ED50 for aortic relaxation (88 ± 7 µM). Conversely, at their ED50 for aortic relaxation diltiazem depressed myocardial contractility and amrinone did not... Tipo: Info:eu-repo/semantics/article Palavras-chave: Amrinone; Dobutamine; Diltiazem; Saphenous vein; Mammary artery. Ano: 2004 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004000600015 Head-to-head comparison of dipyridamole, dobutamine and pacing stress echocardiography for the detection of myocardial ischemia in an animal model of coronary artery stenosis BJMBR Schmidt,A.; de Almeida-Filho,O.C.; Ayres-Neto,E.M.; Carneiro,J.J.; Marin-Neto,J.A.; Maciel,B.C.. To compare the sensitivity of dipyridamole, dobutamine and pacing stress echocardiography for the detection of myocardial ischemia we produced a physiologically significant stenosis in the left circumflex artery of 14 open-chest dogs (range: 50 to 89% reduction in luminal diameter). In each study, dobutamine (5 to 40 µg kg-1 min-1 in 3-min stages) and pacing (20 bpm increments, each 2 min, up to 260 bpm) were performed randomly, and then followed by dipyridamole (up to 0.84 mg/kg over 10 min). The positivity of stress echocardiography tests was quantitatively determined by a significant (P<0.05) reduction of or failure to increase absolute and percent systolic wall thickening in the stenotic artery supplied wall, as compared to the opposite wall (areas... Tipo: Info:eu-repo/semantics/article Palavras-chave: Stress echocardiography; Pacing; Dobutamine; Dipyridamole; Animal model. Ano: 2001 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001000700010 Registros recuperados: 4 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco